Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Convergent Effects of a Functional C3 Variant on Brain Atrophy, Demyelination, and Cognitive Impairment in Multiple Sclerosis Publisher



Roostaei T1, 2, 4, 5, 6, 7, 9, 10, 12, 14, 15, 16, 17, 18, 20, 21, 22 ; Sadaghiani S1, 2, 4, 5, 6, 7, 10, 14, 15, 20 ; Mashhadi R3 ; Falahatian M1, 2, 4, 5, 6, 7, 10, 13 ; Mohamadi E1, 2, 4, 5, 6, 7, 10 ; Javadian N1, 2, 4, 5, 6, 7, 10 ; Nazeri A1, 2, 4, 5, 6, 7, 10, 11, 23 ; Doosti R1, 2, 4, 5, 6, 7, 10 ; Naser Moghadasi A1, 2, 4, 5, 6, 7, 10, 19 ; Owji M1, 2, 4, 5, 6, 7, 10 ; Hashemi Taheri AP8 ; Shakouri Rad A8 ; Azimi A1, 2, 4, 5, 6, 7, 10, 19 ; Voineskos AN9, 12, 16, 17, 21, 22 Show All Authors
Authors
  1. Roostaei T1, 2, 4, 5, 6, 7, 9, 10, 12, 14, 15, 16, 17, 18, 20, 21, 22
  2. Sadaghiani S1, 2, 4, 5, 6, 7, 10, 14, 15, 20
  3. Mashhadi R3
  4. Falahatian M1, 2, 4, 5, 6, 7, 10, 13
  5. Mohamadi E1, 2, 4, 5, 6, 7, 10
  6. Javadian N1, 2, 4, 5, 6, 7, 10
  7. Nazeri A1, 2, 4, 5, 6, 7, 10, 11, 23
  8. Doosti R1, 2, 4, 5, 6, 7, 10
  9. Naser Moghadasi A1, 2, 4, 5, 6, 7, 10, 19
  10. Owji M1, 2, 4, 5, 6, 7, 10
  11. Hashemi Taheri AP8
  12. Shakouri Rad A8
  13. Azimi A1, 2, 4, 5, 6, 7, 10, 19
  14. Voineskos AN9, 12, 16, 17, 21, 22
  15. Nazeri A1, 2, 4, 5, 6, 7, 10, 11, 23
  16. Sahraian MA1, 2, 4, 5, 6, 7, 10, 19
Show Affiliations
Authors Affiliations
  1. 1. Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences and Sina Hospital, Tehran, Iran
  2. 2. Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences and Sina Hospital, Tehran, Iran
  3. 3. Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences and Sina Hospital, Tehran, Iran
  5. 5. Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences and Sina Hospital, Tehran, Iran
  6. 6. Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences and Sina Hospital, Tehran, Iran
  7. 7. Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences and Sina Hospital, Tehran, Iran
  8. 8. Department of Radiology, Tehran University of Medical Sciences, Tehran, Iran
  9. 9. Kimel Family Translational Imaging-Genetics Laboratory, Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada
  10. 10. Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences and Sina Hospital, Tehran, Iran
  11. 11. Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, United States
  12. 12. Department of Psychiatry, University of Toronto, Toronto, ON, Canada
  13. 13. School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  14. 14. Interdisciplinary Neuroscience Research Program, Tehran University of Medical Sciences, Tehran, Iran
  15. 15. Interdisciplinary Neuroscience Research Program, Tehran University of Medical Sciences, Tehran, Iran
  16. 16. Kimel Family Translational Imaging-Genetics Laboratory, Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada
  17. 17. Department of Psychiatry, University of Toronto, Toronto, ON, Canada
  18. 18. Center for Translational and Computational Neuroimmunology, Department of Neurology, Columbia University Medical Center, New York, NY, United States
  19. 19. Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
  20. 20. Interdisciplinary Neuroscience Research Program, Tehran University of Medical Sciences, Tehran, Iran
  21. 21. Kimel Family Translational Imaging-Genetics Laboratory, Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada
  22. 22. Department of Psychiatry, University of Toronto, Toronto, ON, Canada
  23. 23. Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, United States

Source: Multiple Sclerosis Journal Published:2019


Abstract

Background: Complement system activation products are present in areas of neuroinflammation, demyelination, and neurodegeneration in brains of patients with multiple sclerosis (MS). C3 is a central element in the activation of complement cascades. A common coding variant in the C3 gene (rs2230199, C3R102G) affects C3 activity. Objectives: To assess the effects of rs2230199 on MS severity using clinical, cognitive, and imaging measures. Methods: In total, 161 relapse-onset MS patients (Expanded Disability Status Scale (EDSS) ≤ 6) underwent physical assessments, cognitive tests (Paced Auditory Serial Addition Test (PASAT), Symbol Digit Modalities Test (SDMT), and California Verbal Learning Test (CVLT)), and magnetic resonance imaging (MRI). Lesion volumes were quantified semi-automatically. Voxel-wise analyses were performed to assess the effects of rs2230199 genotype on gray matter (GM) atrophy (n = 155), white matter (WM) fractional anisotropy (FA; n = 105), and WM magnetization transfer ratio (MTR; n = 90). Results: While rs2230199 minor-allele dosage (C3-102G) showed no significant effect on EDSS and Multiple Sclerosis Functional Composite (MSFC), it was associated with worse cognitive performance (p = 0.02), lower brain parenchymal fraction (p = 0.003), and higher lesion burden (p = 0.02). Moreover, voxel-wise analyses showed lower GM volume in subcortical structures and insula, and lower FA and MTR in several WM areas with higher copies of rs2230199 minor allele. Conclusion: C3-rs2230199 affects white and GM damage as well as cognitive impairment in MS patients. Our findings support a causal role for complement system activity in the pathophysiology of MS. © The Author(s), 2018.
Other Related Docs
9. Covid-19 Among Patients With Multiple Sclerosis a Systematic Review, Neurology: Neuroimmunology and NeuroInflammation (2021)
19. Serum Mercury Level and Multiple Sclerosis, Biological Trace Element Research (2012)
29. Concurrent Glioma and Multiple Sclerosis: A Systematic Review of Case Reports, Multiple Sclerosis and Related Disorders (2024)
32. Seizure in Iranian Patients With Multiple Sclerosis, Journal of Research in Medical Sciences (2013)
34. Prevalence of Familial Multiple Sclerosis in Isfahan, Iran, Journal of Isfahan Medical School (2011)